DE60310059D1 - Diagnose von karzinomen mit hilfe des raig1-polypeptids - Google Patents

Diagnose von karzinomen mit hilfe des raig1-polypeptids

Info

Publication number
DE60310059D1
DE60310059D1 DE60310059T DE60310059T DE60310059D1 DE 60310059 D1 DE60310059 D1 DE 60310059D1 DE 60310059 T DE60310059 T DE 60310059T DE 60310059 T DE60310059 T DE 60310059T DE 60310059 D1 DE60310059 D1 DE 60310059D1
Authority
DE
Germany
Prior art keywords
polypeptide
cancer
carcinoma
diagnosis
help
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310059T
Other languages
English (en)
Other versions
DE60310059T2 (de
Inventor
J A Terrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0208331A external-priority patent/GB0208331D0/en
Priority claimed from GB0221538A external-priority patent/GB0221538D0/en
Application filed by UCB SA filed Critical UCB SA
Publication of DE60310059D1 publication Critical patent/DE60310059D1/de
Application granted granted Critical
Publication of DE60310059T2 publication Critical patent/DE60310059T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60310059T 2002-04-11 2003-04-10 Diagnose von karzinomen mit hilfe des raig1-polypeptids Expired - Lifetime DE60310059T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0208331A GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins
GB0208331 2002-04-11
GB0221538 2002-09-17
GB0221538A GB0221538D0 (en) 2002-09-17 2002-09-17 A protein involved in carcinoma
PCT/GB2003/001587 WO2003087832A2 (en) 2002-04-11 2003-04-10 Diagnosis of carcinoma using raigi polypeptides

Publications (2)

Publication Number Publication Date
DE60310059D1 true DE60310059D1 (de) 2007-01-11
DE60310059T2 DE60310059T2 (de) 2007-05-10

Family

ID=29252443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310059T Expired - Lifetime DE60310059T2 (de) 2002-04-11 2003-04-10 Diagnose von karzinomen mit hilfe des raig1-polypeptids

Country Status (8)

Country Link
US (2) US20050282165A1 (de)
EP (1) EP1497656B1 (de)
JP (2) JP2005522226A (de)
AT (1) ATE347106T1 (de)
AU (1) AU2003222606A1 (de)
DE (1) DE60310059T2 (de)
ES (1) ES2274220T3 (de)
WO (1) WO2003087832A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004001060A2 (en) * 2002-06-20 2003-12-31 Bristol-Myers Squibb Company Identification and regulation of a g-protein coupled receptor, rai-3
JPWO2021045224A1 (de) * 2019-09-04 2021-03-11

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068618A1 (en) * 2000-07-26 2003-04-10 Muralidharu Padigaru Novel proteins and nucleic acids encoding same
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US20070015148A1 (en) * 2001-01-25 2007-01-18 Orr Michael S Gene expression profiles in breast tissue
AU2002324451A1 (en) * 2001-06-21 2003-01-08 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer

Also Published As

Publication number Publication date
ES2274220T3 (es) 2007-05-16
US20090258019A1 (en) 2009-10-15
AU2003222606A1 (en) 2003-10-27
US20050282165A1 (en) 2005-12-22
WO2003087832A3 (en) 2004-02-12
EP1497656A2 (de) 2005-01-19
DE60310059T2 (de) 2007-05-10
ATE347106T1 (de) 2006-12-15
JP2010117358A (ja) 2010-05-27
WO2003087832A2 (en) 2003-10-23
AU2003222606A8 (en) 2003-10-27
EP1497656B1 (de) 2006-11-29
JP2005522226A (ja) 2005-07-28

Similar Documents

Publication Publication Date Title
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
ATE435232T1 (de) Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden
ATE302278T1 (de) Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen
ATE537258T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
ES2182297T3 (es) Deteccion y modulacion de lo inhibidores de las proteinas de la apoptosis (iaps) y de los polipeptidos anti-apoptoticos afines (naip) para la diagnosis y tratamiento de enfermedades proliferativas.
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
CY1106966T1 (el) Αντισωμα αντι-αpο-2
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
AU4929701A (en) Whole-body optical imaging of gene expression and uses thereof
DE69839123D1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ATE302274T1 (de) Methoden zur bestimmung von komponenten zur modulation des körpergewichts
EA200700951A1 (ru) БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG
DE60310059D1 (de) Diagnose von karzinomen mit hilfe des raig1-polypeptids
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
WO2003087840A3 (en) Protein involved in cancer
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
ATE291738T1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
NZ512332A (en) Potassium channel interactors and uses therefor
WO2006000753A3 (en) Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition